ACRS FY 2018 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$407M

FY 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$10M+499.6% YoY

Gross Profit

$3M32.1% margin

Operating Income

-$135M-1341.9% margin

Net Income

-$133M-1315.4% margin

EPS (Diluted)

$-4.03

Cash Flow

Operating Cash Flow

-$101M

Free Cash Flow

-$102M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$276M

Total Liabilities

$60M

Stockholders' Equity

$215M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$2M	+499.6%
Gross Profit	$3M	$476,000	+580.9%
Operating Income	-$135M	-$72M	-87.0%
Net Income	-$133M	-$69M	-93.7%